Pre-clinical in vitro and in vivo evidence to support personalized biologic treatment of endometrial cancer with metformin and PI3K pathway inhibitors
D. Iglesias, J. Burzawa, Q. Zhang, N. CO, J. Celestino, M. Yates, D. Gershenson, R. Schmandt, K. LuVolume:
125
Year:
2012
Language:
english
Pages:
1
DOI:
10.1016/j.ygyno.2011.12.331
File:
PDF, 60 KB
english, 2012